Biogen Inc Webcast on ALS Portfolio Corporate Call Transcript
Good morning. My name is Jessa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen webcast on ALS portfolio. (Operator Instructions)
I would now like to turn the conference over to Mr. Matt Calistri, Vice President, Investor Relations. You may begin your conference.
Thank you, Jessa. Welcome to today's webcast to review our strategy and R&D progress in amyotrophic lateral sclerosis, or ALS. I want to thank you all for joining us this morning.
Before we begin, I encourage everyone to go to the Investors section of biogen.com to find slides that will accompany the discussion related to this call. I want to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |